Taiwan Kong King Co.,Ltd (TPEX:3093)

Market Cap	4.46B
Revenue (ttm)	1.71B
Net Income (ttm)	193.53M
Shares Out	145.16M
EPS (ttm)	1.33
PE Ratio	23.03
Forward PE	n/a
Dividend	1.08 (3.86%)
Ex-Dividend Date	Jul 2, 2025

Volume	213,000
Average Volume	217,080
Open	32.70
Previous Close	30.70
Day's Range	31.60 - 33.75
52-Week Range	18.25 - 33.30
Beta	0.66
RSI	75.82
Earnings Date	Aug 8, 2025

About Sage Therapeutics

Taiwan Kong King Co.,Ltd acts as a specialized agent for electronics related manufacturers in Taiwan and China. The company offers printed circuit boards (PCBs), Flex PCBs, semiconductors, LEDs, and chemical materials; and surface mount technology, solar, and optoelectronic communication equipment. It also provides equipment installation, repair, maintenance, inspection, renovation, upgradation, and relocation services, as well as technical training services; and flying probe and fixture contract service for O/S testing. Taiwan Kong King Co.,Lt...

• Industry: Electronic Components
• Sector: Technology
• Founded: 1977
• Employees: 248
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3093

Financial Performance

In 2024, Taiwan Kong King Co.,Ltd's revenue was 1.34 billion, a decrease of -25.41% compared to the previous year's 1.80 billion. Earnings were 154.01 million, a decrease of -47.36%.

Financial numbers in IDR